Literature DB >> 8228825

Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus.

T D Brumeanu1, W J Swiggard, R M Steinman, C A Bona, H Zaghouani.   

Abstract

Several prior reports have identified peptides that are naturally associated with major histocompatibility complex (MHC) class II molecules on presenting cells. We have examined the delivery of a peptide from exogenous sources to MHC class II molecules. The peptide derives from the influenza virus hemagglutinin (HA) and activates a CD4+ T cell hybridoma. In functional assays of antigen presentation, this epitope is delivered effectively to T cells either in the context of influenza virus or chimeric immunoglobulin (Ig) molecules (Ig-HA) in which the peptide has replaced the CDR3 loop of the heavy chain. We find that the identical 11-mer peptide can be isolated from mouse MHC class II antigens whether the exogenous source of peptide is free HA peptide, the Ig-HA chimera, or ultraviolet-inactivated PR8 influenza virus. The Ig-HA chimera proves to be the most efficient vehicle for charging class II molecules via the exogenous route. Given the fact that self Igs represent natural long-lived carriers, we suggest that antigenized Igs have considerable potential for peptide delivery to MHC molecules in situ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228825      PMCID: PMC2191225          DOI: 10.1084/jem.178.5.1795

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.

Authors:  C A Nelson; R W Roof; D W McCourt; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.

Authors:  P Preston-Hurlburt; B K al-Ramadi; J Rothbard; C A Janeway
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

3.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Authors:  D F Hunt; H Michel; T A Dickinson; J Shabanowitz; A L Cox; K Sakaguchi; E Appella; H M Grey; A Sette
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

4.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

5.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

6.  Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule.

Authors:  H Zaghouani; R Steinman; R Nonacs; H Shah; W Gerhard; C Bona
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

7.  A large degree of functional diversity exists among helper T cells specific for the same antigenic site of influenza hemagglutinin.

Authors:  A M Haberman; C Moller; D McCreedy; W U Gerhard
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

8.  Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen.

Authors:  G Chimini; P Pala; J Sire; B R Jordan; J L Maryanski
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.

Authors:  K Falk; O Rötzschke; K Deres; J Metzger; G Jung; H G Rammensee
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

10.  Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product.

Authors:  Y S Hahn; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  13 in total

1.  Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Authors:  K Manoutcharian; L I Terrazas; G Gevorkian; G Acero; P Petrossian; M Rodriguez; T Govezensky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 3.  Antigen-specific therapeutic approaches in Type 1 diabetes.

Authors:  Xavier Clemente-Casares; Sue Tsai; Carol Huang; Pere Santamaria
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

4.  Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.

Authors:  H Zaghouani; S A Anderson; K E Sperber; C Daian; R C Kennedy; L Mayer; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.

Authors:  S Kodihalli; D M Justewicz; L V Gubareva; R G Webster
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Antibodies designed as effective cancer vaccines.

Authors:  R L Metheringham; V A Pudney; B Gunn; M Towey; I Spendlove; L G Durrant
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

7.  Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis.

Authors:  K L Legge; B Min; J J Bell; J C Caprio; L Li; R K Gregg; H Zaghouani
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

8.  Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing.

Authors:  K L Legge; B Min; N T Potter; H Zaghouani
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

9.  Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy.

Authors:  B Min; K L Legge; C Pack; H Zaghouani
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity.

Authors:  Kevin L Legge; Randal K Gregg; Roberto Maldonado-Lopez; Lequn Li; Jacque C Caprio; Muriel Moser; Habib Zaghouani
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.